English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Diversity Innovation Hub (DIH) at the Icahn School of Medicine at Mount Sinai is among the Top 50 in Digital Health for 2020.
Tag: Icahn School of Medicine at Mount Sinai
Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research
The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai has received more than $10 million in federal funding for several projects focusing on brain tumor research.
Researchers Identify Potential Formula for Blood Cancer Vaccine
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy for multiple myeloma, a blood cancer, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, in December.
Caring for Transgender Persons: What Clinicians Should Know
The New England Journal of Medicine review by Mount Sinai experts will serve as a major resource and guide for all physicians looking for best care strategies
Genetic Breakthrough Identifies Heart Failure Risk in African and Latino Americans
Findings may inform genetic screening test for patients at risk and medically under-served
Mone Zaidi, MD, PhD, Named Fellow of the American Association for the Advancement of Science
Mone Zaidi, MD, PhD, Director of the Mount Sinai Bone Program, has been named a Fellow of the American Association for the Advancement of Science (AAAS)
Mount Sinai Researchers Uncover New Molecular Drivers of Parkinson’s Disease
New Approach Will Lead to a Better Understanding of Most Cases
Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer Drug
Recent study found that an effective blood cancer treatment was associated with weight gain, obesity, and increased systolic blood pressure
Teaching Preschool Caregivers about Healthy Behaviors May Promote Healthier Lifestyle in Some High-Risk Groups
Study Shows Vascular Ultrasounds and Adhering to Interventional Education in Underserved Communities can Improve Health among Parents and School Staff
Mount Sinai Researchers Develop Novel Method to Identify Patterns Among Patients With Multiple Chronic Conditions
A study by researchers at Icahn School of Medicine at Mount Sinai proposes a novel method for identifying patterns in the frequency and cost of multiple chronic conditions (MCC).
Human Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug
The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.
Prostate Cancer Research Gala Recognizes Innovations in Treatment and Patient Care
Atlanta Falcons and Atlanta United owner Arthur Blank and Nina Bhardwaj, MD, PhD, will be honored for their contributions to prostate cancer research.
Eye Damage Linked to Popular Over-the-Counter Vitamin That Lowers Cholesterol Can Be Reversed
Study is the first to identify specific cellular toxicity and show improvement after stopping supplement use
Icahn School of Medicine at Mount Sinai Launches First-Of-Its-Kind Diversity Innovation Hub to Use Technology to Close Gaps in Local Health Care
The Icahn School of Medicine at Mount Sinai – an international leader in medical and scientific training, biomedical research, and patient care – today announced the launch of a new Diversity and Inclusion Hub, a groundbreaking initiative spearheaded by the Mount Sinai’s Office of Diversity and Inclusion.
Mount Sinai Researchers Bring Us One Step Closer to Universal Influenza Vaccine
A team led by researchers at the Icahn School of Medicine at Mount Sinai is getting closer to a universal flu vaccine using a novel approach they’ve developed called chimeric hemagglutinin (cHA).
Artificial Pancreas System Better Controls Blood Glucose Levels than Current Technology
Study based at the Icahn School of Medicine at Mount Sinai and other centers finds new system has safety, efficacy benefits for people with type 1 diabetes
Tape Strips Identified as Non-Invasive Approach to Assess Skin Biomarkers in Children With Atopic Dermatitis
May also help predict therapeutic responses
Optimism Linked to Lower Risk of Cardiovascular Events and Death
Research identifies a new target for helping patients decrease risk of heart disease and promote health
Coronary Stent Patients May Not Need Long-Term Aspirin
Results from international clinical trial ‘TWILIGHT’ could change standard of care for high-risk cases
First-Of-Its Kind Research Examines the Relationship Between Asthma, Disease Control, and Depression
$3.4 Million Study to Understand Why Older Adults Have Worse Asthma Outcomes
Mount Sinai Ranked Among the Top in the Nation by U.S. News & World Report
The Hospital was ranked No. 14 nationally, up four spots from last year. Eight departments within the Hospital were ranked among the top 20 nationally in their specialties, up from five last year
Discovery’s Science Channel Partners With Mount Sinai Health System to Create Digital Series Featuring Innovations in Science and Medicine
Discovery’s Science Channel has teamed up with Mount Sinai Health System, one of the country’s leading academic medical institutions, to showcase some of the groundbreaking innovations in science and medicine that are transforming health care and providing new treatments for…